GleamWall
中文EN

REFR RESEARCH FRONTIERS INC

Patent Owners & Lessors · Nasdaq · SEC CIK 793524 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-69.7%
TTM net income YoY-30.4%
TTM EPS YoY-16.7%
Revenue 3-yr CAGR-20.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-670.2%
Net margin-662.0%
FCF margin-500.4%
EBITDA margin-669.3%

Returns

ROE-233.1%
ROA-104.1%
ROIC (approx.)-1,167.3%
Asset turnover0.16x

Leverage & solvency

Liabilities / assets68.7%
Debt / equity0.00x
Current ratio2.21x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.76x
Accruals ratio-25.4%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$77,041$86,346$136,319$72,123$359,444$129,904$559,776$178,151
R&D expense$119,574$128,884$145,350$135,023$141,746$169,086$162,877$160,190
Operating income-$518,121-$669,754-$530,413-$773,543-$303,944-$815,104-$239,577-$624,284
Net income-$510,304-$660,168-$525,365-$765,563-$298,508-$803,826-$177,687-$607,940
EBITDA-$517,805-$669,267-$530,269-$771,344-$301,065-$812,240-$236,717-$620,517
EPS (basic)-0.01-0.02-0.02—-0.01-0.02-0.01—
EPS (diluted)-0.01-0.02-0.02—-0.01-0.02-0.01—
Weighted avg. shares (diluted)34.87M34.87M34.16M—33.65M33.65M33.65M—
Balance sheet
Cash & equivalents$644,628$1.09M$1.28M$664,299$1.13M$1.27M$1.35M$1.99M
Receivables$223,853$207,955$544,985$408,666$371,878$536,373$969,059$658,213
Current assets$982,668$1.46M$2.02M$1.14M$1.61M$1.97M$2.52M$2.75M
PP&E, net$2,559$2,867$3,147$3,393$6,355$9,095$12,082$15,052
Total assets$1.96M$2.48M$3.08M$2.25M$2.77M$3.17M$3.77M$4.04M
Current liabilities$444,603$410,885$316,107$297,877$212,088$280,235$210,708$269,027
Total liabilities$1.35M$1.35M$1.30M$1.32M$1.27M$1.37M$1.34M$1.44M
Shareholders' equity$612,789$1.12M$1.78M$933,626$1.50M$1.80M$2.43M$2.60M
Shares outstanding34.87M34.87M34.87M33.65M33.65M33.65M33.65M33.65M
Cash flow statement
Operating cash flow-$443,320-$191,307-$759,931-$465,947-$143,513-$78,430-$641,271$47,080
Capital expenditure$8$38$67$144$373$99$110$881
Free cash flow-$443,328-$191,345-$759,998-$466,091-$143,886-$78,529-$641,381$46,199
Investing cash flow-$8-$38-$67-$144-$373-$99-$110-$881
Financing cash flow$0$0$1.38M————$300,000
Depreciation & amortization$316$487$144$2,199$2,879$2,864$2,860$3,767
Stock-based compensation———$199,671$0———

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.